Increased risk of heart rhythm problems with lamotrigine: Drug safety alert from USFDA

Lamotrigine is an anticonvulsant medicine been in the market for more than 25 years with the brand name Lamictal and also available in generics. It is used in the treatment of epileptic seizures and also as maintenance treatment for delaying the occurrence of mood episodes such as depression, mania, or hypomania in patients with the

Propylhexedrine: Potential risk of drug misuse, abuse and serious health consequences

United States Food & Drug administration (USFDA) released a drug safety communication to bring more awareness on potential drug misuse and abuse of propylhexedrine associated with serious complications like abnormal heart rhythm, high blood pressure, and paranoia. It is marketed under the brand name Benzedrex. Propylhexedrine is a nasal decongestant available in the retail pharmacy

Notice: Undefined variable: shuttle_blog_postswitch in /var/www/wp-content/themes/shuttle-pro/admin/main/options/05.blog.php on line 634
class="blog-article post-2801 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-safety-alert category-drug-safety-updates category-global-safety-alerts category-medicinal-product-updates category-safety-communications category-us-fda category-us-fda-global-safety-alerts tag-nsaid tag-oligohydramnios tag-pregnancy tag-usfda-drug-safety-communication format-media">
Oligohydramnios associated with NSAID use in Pregnancy-Safety Communication from USFDA

Oligohydramnios associated with NSAID use in Pregnancy-Safety Communication from USFDA

United States Food and Drug Administration (US-FDA) has issued a safety communication on the potential risk of oligohydramnios in pregnant women when exposed to medicinal products that belongs to the class of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) during pregnancy of 20 weeks gestational age. FDA issued this communication to alert health care professionals and consumers for

Notice: Undefined variable: shuttle_blog_postswitch in /var/www/wp-content/themes/shuttle-pro/admin/main/options/05.blog.php on line 634
class="blog-article post-2768 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-safety-alert category-global-safety-alerts category-medicinal-product-updates category-us-fda category-us-fda-global-safety-alerts category-voluntary-adr-reporting tag-benadryl-challenge tag-diphenhydramine-acute-toxicity tag-diphenhydramine-overdose tag-usfda-drug-safety-communication format-media">
“Benadryl Challenge” in Social media: USFDA warns about serious safety concerns associated with diphenhydramine overdose

“Benadryl Challenge” in Social media: USFDA warns about serious safety concerns associated with diphenhydramine overdose

U.S. Food and Drug Administration (FDA) alerted health care professionals and general public through recent drug safety communication which concerns about serious risks (heart problems, seizures, coma, and sometimes fatal outcomes) due to allergy medicine-diphenhydramine administration higher than the recommended dosage and overdose occurrences due to ‘Benadryl Challenge’ circulating in Social media- TikTok. Diphenhydramine is

Notice: Undefined variable: shuttle_blog_postswitch in /var/www/wp-content/themes/shuttle-pro/admin/main/options/05.blog.php on line 634
class="blog-article post-2625 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-safety-updates category-global-safety-alerts category-medicinal-product-updates category-pharmacovigilance category-safety-communications category-us-fda category-us-fda-global-safety-alerts category-voluntary-adr-reporting tag-naloxone tag-opioid-overdose tag-opioid-use-disorder tag-usfda-drug-safety-communication format-media">
Naloxone use for opioid use disorder: US-FDA recommendation

USFDA Drug Safety Communication: Naloxone use for opioid use disorder

On 23-Jul-2020, United States Food and Drug Administration (USFDA) has released a recommendation for the use of Naloxone in the treatment of opioid use disorder and for patients who are at increased risk of opioid overdose. Opioids are a class of drugs which are used to reduce moderate to severe pain in patients who are

error: Content is protected !!